LEXICON PHARMACEUTICALS INC. - COMMON STOCK

Lexicon Announces Virtual Webcast on LX9211 for Diabetic Peripheral Neuropathic Pain

21 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Lexicon Appoints Scott Coiante as Chief Financial Officer

02 Jan 2025 07:00:00 By Nasdaq GlobeNewswire

Lexicon Announces Receipt of Complete Response Letter for Zynquista™ (sotagliflozin)

20 Dec 2024 15:30:55 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

05 Dec 2024 08:47:08 By NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

04 Dec 2024 09:21:04 By NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

03 Dec 2024 12:14:59 By NetDania Notify

Lexicon Announces Completion of Enrollment in Phase 2B PROGRESS Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

26 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in December Investor Conferences

25 Nov 2024 15:15:00 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

22 Nov 2024 08:45:08 By NetDania Notify

Lexicon to Reposition as Clinical Development-Focused Company Following Regulatory Update From FDA

22 Nov 2024 06:32:16 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

21 Nov 2024 09:19:30 By NetDania Notify

Lexicon Appoints Ivan H. Cheung to Board of Directors

20 Nov 2024 15:05:47 By Nasdaq GlobeNewswire

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

20 Nov 2024 08:58:26 By NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

19 Nov 2024 08:45:33 By NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

18 Nov 2024 08:46:19 By NetDania Notify

NetDania - New 12 months Low: LEXICON PHARMACEUTICALS INC. - COMMON STOCK

15 Nov 2024 08:51:39 By NetDania Notify

Post-Hoc Analysis Demonstrating Sotagliflozin Benefits Across Broad Spectrum of Heart Failure Patient Populations is Among Four Lexicon-Supported Presentations at the American Heart Association’s (AHA) Sessions 2024 in Chicago

14 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

12 Nov 2024 15:05:00 By Nasdaq GlobeNewswire

Lexicon Pharmaceuticals to Participate in the Jefferies London Global Healthcare Conference

06 Nov 2024 07:00:00 By Nasdaq GlobeNewswire

Published Data in Journal of American Society of Nephrology Highlights Findings on Efficacy and Safety of Sotagliflozin for People With Type 1 Diabetes and Chronic Kidney Disease

05 Nov 2024 15:05:00 By Nasdaq GlobeNewswire